<DOC>
	<DOCNO>NCT00687609</DOCNO>
	<brief_summary>The purpose study determine whether atomoxetine effective reduce ADHD ( Attention Deficit/Hyperactivity Disorder ) symptoms adolescent ADHD comorbid cannabis abuse .</brief_summary>
	<brief_title>Pilot Evaluation Atomoxetine Attention Deficit Hyperactivity Disorder ( ADHD ) Symptoms Adolescents With Cannabis abusE</brief_title>
	<detailed_description>In past adolescent cannabis abuse exclude study atomoxetine ADHD symptom study . In study efficacy atomoxetine symptom ADHD adolescent ADHD comorbid cannabis abuse study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Diagnosis ADHD base Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) At least 1.5 standard deviation age norm diagnostic subtype use publish norm ADHD Rating ScaleIVParent Version Cannabis Abuse dependence base DSMIVTR , use minimum 5 joint per week Weight 20 kilogram ( kg ) Patients serious suicidal risk Patients alcohol drug abuse ( cannabis ) Patients investigator 's judgement likely need psychotropic medication + psychotherapy apart atomoxetine</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder Cannabis Abuse</keyword>
	<keyword>Marihuana Abuse</keyword>
	<keyword>Comorbid Cannabis Abuse</keyword>
</DOC>